Brief: ExpreS2ion's JV AdaptVac Receives Grant
Feb 25 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* EXPRES2ION'S JOINT VENTURE ADAPTVAC RECEIVES EUROSTARS
GRANT TO
FURTHER SUPPORT ITS HER2 VACCINE PROJECT AV001
* JOINT VENTURE ADAPTVAC HAS BEEN AWARDED A 0.6 MEUR
EUROSTARS
GRANT, OF WHICH ADAPTVAC DIRECTLY RECEIVES 1.3 MDKK (1.8 MSEK)
* EXPECTS TO RECEIVE 0.7 MDKK (1.0 MSEK) FROM THIS GRANT
Source text for Eikon: ID:nWkr1N3vMx
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations